메뉴 건너뛰기
Oncologist
Volumn 12, Issue 11, 2007, Pages 1371-1372
The usefulness of nerve conduction studies in objectively assessing oxaliplatin-induced peripheral neuropathy [1]
Author keywords

[No Author keywords available]
Indexed keywords

ANTINEOPLASTIC AGENT; FLUOROURACIL; FOLINIC ACID; GLUTAMINE; OXALIPLATIN; OXCARBAZEPINE; PLACEBO;
EID: 36849070742     PISSN: 10837159     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.12-11-1371     Document Type: Letter
Times cited : (9)
References (7)
  • 1
    • 34147102323 scopus 로고    scopus 로고
    • Oral glutamine is effective for preventing oxaliplatin-induced neuropathy in colorectal cancer patients
    • Wang WS, Lin JK, Lin TC et al. Oral glutamine is effective for preventing oxaliplatin-induced neuropathy in colorectal cancer patients. The Oncologist 2007;12:312-319.
    • (2007) The Oncologist , vol.12 , pp. 312-319
    • Wang, W.S.1    Lin, J.K.2    Lin, T.C.3
  • 2
    • 0037102328 scopus 로고    scopus 로고
    • Neuroprotective effect of reduced glutathione on oxaliplatin-based chemotherapy in advanced colorectal cancer: A randomized, double-blind, placebo-controlled trial
    • Cascinu S, Catalano V, Cordella L et al. Neuroprotective effect of reduced glutathione on oxaliplatin-based chemotherapy in advanced colorectal cancer: A randomized, double-blind, placebo-controlled trial. J Clin Oncol 2002;20:3478-3483.
    • (2002) J Clin Oncol , vol.20 , pp. 3478-3483
    • Cascinu, S.1    Catalano, V.2    Cordella, L.3
  • 3
    • 33845915641 scopus 로고    scopus 로고
    • Efficacy of oxcarbazepine for prophylaxis against cumulative oxaliplatin-induced neuropathy
    • Argyriou AA, Chroni E, Polychronopoulos P et al. Efficacy of oxcarbazepine for prophylaxis against cumulative oxaliplatin-induced neuropathy. Neurology 2006;67:2253-2255.
    • (2006) Neurology , vol.67 , pp. 2253-2255
    • Argyriou, A.A.1    Chroni, E.2    Polychronopoulos, P.3
  • 4
    • 0036158822 scopus 로고    scopus 로고
    • Chemotherapy-induced peripheral neuropathy
    • Quasthoff S, Hartung HP. Chemotherapy-induced peripheral neuropathy. J Neurol 2002;249:9-17.
    • (2002) J Neurol , vol.249 , pp. 9-17
    • Quasthoff, S.1    Hartung, H.P.2
  • 5
    • 35848931912 scopus 로고    scopus 로고
    • Incidence and characteristics of peripheral neuropathy during oxaliplatin-based chemotherapy for metastatic colon cancer
    • Jun 21 [Epub ahead of print; doi: 10.1080/02841860701355055
    • Argyriou AA, Polychronopoulos P, Iconomou G et al. Incidence and characteristics of peripheral neuropathy during oxaliplatin-based chemotherapy for metastatic colon cancer. Acta Oncol 2007; Jun 21 [Epub ahead of print; doi: 10.1080/02841860701355055].
    • (2007) Acta Oncol
    • Argyriou, A.A.1    Polychronopoulos, P.2    Iconomou, G.3
  • 6
    • 0028270476 scopus 로고
    • Peripheral neuropathy from taxol and cisplatin combination chemotherapy: Clinical and electrophysiological studies
    • Chaudhry V, Rowinsky EK, Sartorius SE et al. Peripheral neuropathy from taxol and cisplatin combination chemotherapy: Clinical and electrophysiological studies. Ann Neurol 1994;35:304-311.
    • (1994) Ann Neurol , vol.35 , pp. 304-311
    • Chaudhry, V.1    Rowinsky, E.K.2    Sartorius, S.E.3
  • 7
    • 22844448647 scopus 로고    scopus 로고
    • Peripheral neuropathy induced by administration of cisplatin- and paclitaxel-based chemotherapy. Could it be predicted?
    • Argyriou AA, Polychronopoulos P, Koutras A et al. Peripheral neuropathy induced by administration of cisplatin- and paclitaxel-based chemotherapy. Could it be predicted? Support Care Cancer 2005;13:647-651.
    • (2005) Support Care Cancer , vol.13 , pp. 647-651
    • Argyriou, A.A.1    Polychronopoulos, P.2    Koutras, A.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.